Intelligence / TB-500

TB-500

Prescription Only
Tissue Repair
Schedule
S4
Prescription Only
Enforcement
Monitoring
Medium Risk
Providers
8
Access: Limited
Key Facts
Schedule 4 - Prescription Only
Synthetic Thymosin Beta-4 fragment
8 identified Australian providers
Some pharmacies have discontinued
Grey market availability remains high

Overview

TB-500 is a synthetic version of a naturally occurring 43-amino acid peptide (Thymosin Beta-4). Prescription availability is more limited than BPC-157, with some compounding pharmacies discontinuing it. Grey market supply remains readily available.

Australian Scheduling

Schedule 4 (Prescription Only). Currently under monitoring by the TGA. Some compounding pharmacies have discontinued TB-500, potentially signalling increased regulatory caution.

Access Pathway

Available through select telehealth providers and compounding pharmacies, but with fewer options than other tissue repair peptides. 8 identified providers. The limited prescription supply has driven demand toward the grey market.

Regulatory Notice

For informational purposes only. TGA scheduling may change without notice. All Schedule 4 peptides require a valid prescription from a registered Australian medical practitioner. This site does not sell, supply, or facilitate access to therapeutic goods. Data compiled from TGA SUSMP, public provider directories, and publicly available review platforms.

Are You a Practitioner?

List your clinic for free and reach patients actively searching for legal peptide access in Australia.